Healthcare coverage affects survival of <i>EGFR-mutant</i> Thai lung cancer patients.

Front Oncol · 2023 · PMC9989298 · PMID 36895484

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In EGFR m-positive patients (n=422), relative survival benefit of EGFR-TKI treatment remained highly significant (aHR[EGFR-TKI]=0.19 [95%CI 0.12–0.29]; aHR(chemotherapy only)=0.50 [95%CI 0.30–0.85]; reference:BSC), indicating that healthcare coverage (reimbursement) affected treatment choice and survival.

also in 132,142 other papers

showed a trendno p-value reported

The CSMBS/SE group also showed a trend toward longer OS compared with the UC/SSS or self-paying groups in multivariate analyses ( Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.